fda compounding semaglutide warning letters october 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of From Crackdown to Collaboration: FDA

retatrutide is investigational and hits three (GIP, GLP-1 and glucagon)

But they need to do it safely and with guidance. Anyone curious about microdosing should start with a conversation, not a syringe, and speak first with a medical provider because microdosing remains a strategy shaped by experience rather than by formal guidelines

Step 2: selection of an appropriate starting tirzepatide dose Many patients begin at a lower tirzepatide dose to improve tolerance

To qualify, you must be 18 or older, participate in the Medicare part D drug coverage program and meet certain health criteria: Have a BMI thats 35 or higher, the threshold for severe obesity Have a BMI between 27 and 34.9 and at least one of the specified obesity-associated health complications for your weight and height Bridge is an experiment